pubmed.ncbi.nlm.nih.gov

High frequency of genomic instability in Ewing family of tumors - PubMed

️Thu Jan 01 2004

Comparative Study

High frequency of genomic instability in Ewing family of tumors

Anat Ohali et al. Cancer Genet Cytogenet. 2004.

Abstract

We tested Ewing sarcoma tumors for microsatellite instability (MSI) and loss of heterozygosity (LOH) to investigate the role of genomic instability (GI) in this sarcoma. We detected a high frequency of GI (57%), mostly on 1p and 11p, 35% and 30%, respectively. Patients with GI compared to those with stable genome had a median progression-free survival (PFS) and overall survival (OS) of 24 months and 70 months, compared with 39 and 84 months, respectively. MSI was observed in 48% (11/23) of the tumor samples. Low-MSI (L-MSI) patients (with MSI presented at only one locus) tended to have a better prognosis, 70% PFS, compared with 25% in the high-MSI (H-MSI) group (P=0.13). LOH without MSI did not correlate with progression. H-GI (MSI and/or LOH in > or =30% of tested markers) tended to associate with an adverse prognosis (P=0.28), and correlated significantly with the pelvic site of the primary tumor (P=0.02). The instability of 1p was not associated with progression, while alterations at the 11p locus tended to correlate with a more aggressive disease (P=0.18). Our data suggest that GI may play a role in Ewing sarcoma clinical behavior and outcome.

PubMed Disclaimer

Comment in

Standard mono- and dinucleotide repeats do not appear to be sensitive markers of microsatellite instability in the Ewing family of tumors.
Ebinger M, Bock T, Kandolf R, Sotlar K, Bültmann BD, Greil J. Ebinger M, et al. Cancer Genet Cytogenet. 2005 Mar;157(2):189-90. doi: 10.1016/j.cancergencyto.2004.08.008. Cancer Genet Cytogenet. 2005. PMID: 15721646 No abstract available.

Cited by

Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets.
Kim J, Kim JH, Kang HG, Park SY, Yu JY, Lee EY, Oh SE, Kim YH, Yun T, Park C, Cho SY, You HJ. Kim J, et al. BMC Med Genet. 2018 Dec 31;19(Suppl 1):216. doi: 10.1186/s12881-018-0722-6. BMC Med Genet. 2018. PMID: 30598078 Free PMC article.
Exploring the landscape of immunotherapy approaches in sarcomas.
Pilavaki P, Panagi M, Arifi S, Jones RL, Stylianopoulos T, Constantinidou A. Pilavaki P, et al. Front Oncol. 2023 Jan 9;12:1069963. doi: 10.3389/fonc.2022.1069963. eCollection 2022. Front Oncol. 2023. PMID: 36686827 Free PMC article. Review.
Clinical and biochemical function of polymorphic NR0B1 GGAA-microsatellites in Ewing sarcoma: a report from the Children's Oncology Group.
Monument MJ, Johnson KM, McIlvaine E, Abegglen L, Watkins WS, Jorde LB, Womer RB, Beeler N, Monovich L, Lawlor ER, Bridge JA, Schiffman JD, Krailo MD, Randall RL, Lessnick SL. Monument MJ, et al. PLoS One. 2014 Aug 5;9(8):e104378. doi: 10.1371/journal.pone.0104378. eCollection 2014. PLoS One. 2014. PMID: 25093581 Free PMC article.
Programmed cell death-1 blockade in recurrent disseminated Ewing sarcoma.
McCaughan GJ, Fulham MJ, Mahar A, Soper J, Hong AM, Stalley PD, Tattersall MH, Bhadri VA. McCaughan GJ, et al. J Hematol Oncol. 2016 Jun 3;9(1):48. doi: 10.1186/s13045-016-0278-x. J Hematol Oncol. 2016. PMID: 27259563 Free PMC article.
Suppression of spontaneous genome rearrangements in yeast DNA helicase mutants.
Schmidt KH, Kolodner RD. Schmidt KH, et al. Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18196-201. doi: 10.1073/pnas.0608566103. Epub 2006 Nov 17. Proc Natl Acad Sci U S A. 2006. PMID: 17114288 Free PMC article.

High frequency of genomic instability in Ewing family of tumors - PubMed